LABORATORY ACTIVITIES Clause Samples

LABORATORY ACTIVITIES. Conducted IATA training regarding procedures for shipment of dangerous goods for laboratory staff. • Provided extensive training to NIC laboratorians on influenza virus typing, subtyping, PCR, RT-PCR, and reverse genetics techniques. • Participated in WHO’s External Quality Assessment Project (EQAP) for the detection of influenza virus type by RT-PCR with successful results (100%). • Participated in the Grant Management Training in Madagascar. • Acquired IATA certification training for seven NIC staff members. • Trained trainers in collaboration with CDC. • Trained select sentinel staff members (laboratory technicians, nurses, doctors, and epidemiologists). • Invited to present at the ANISE Meeting in Cape Town, South Africa (December 2014). • Participated in a Grants Proposal Writing Workshop in Johannesburg, South Africa (Laboratory Head, NIC and the Project Coordinator). • Participated in a training workshop on Laboratory Diagnosis of Influenza and other Emerging Respiratory Viruses, November 2013 in Accra, Ghana (Laboratory Technician).

LABORATORY ACTIVITIES. Disseminated weekly virological surveillance data through the AFR Influenza Laboratory Network. • Provided essential reagents and supplies to Algeria, Burkina Faso, Central Africa Republic, Republic of Congo, Senegal, and Togo for enhancing and sustaining laboratory testing of ILI and SARI clinical specimens. • Provided financial support to the Democratic Republic of Congo in order to strengthen the National Institute of Biomedical Research (INRB) for enhancing virological influenza surveillance. • Strengthened Zimbabwe’s national influenza reference laboratory with financial support. • Ghana and Tanzania—Conducted self-assessment surveys of their influenza laboratory using WHO standardized tools. • Tanzania—Conducted training on influenza specimen collection and shipment for staff • Ghana National Influenza Center (NIC)— Supported sub-regional influenza capacity by training two staff members from Nigeria and Côte d’Ivoire on influenza virus isolation (18–27 March 2015). • Ghana—Established 24 sentinel sites for influenza surveillance in all regions, between January and April 2015, as part of influenza preparedness. Sent samples from patients with ILI for assessment by the NIC. • Participated in and helped facilitate the Influenza Estimating Burden Workshop in Cape Town, South Africa on 4 December 2014. • Supported three participants from Burkina Faso, Niger, and Togo to attend the Grants Proposal Writing Workshop held in Johannesburg, South Africa from 13–17 April 2015. • Organized and facilitated a workshop for preparedness and response to influenza and respiratory pandemics in the context of the International Health Regulations (IHR 2005) in Yaoundé, Cameroon. Thirty participants from eleven countries—Angola, Burundi, Cameroon, Gabon, Central African Republic, Democratic Republic of Congo, Sao Tome and Principe, Senegal, Chad and Equatorial Guinea—in the African region attended the workshop (4–8 November 2013). • Organized a training workshop in Ouagadougou, Burkina Faso on Building the Capacity for Influenza Sentinel Surveillance. Participants were clinicians from sentinel sites, laboratory technicians, and epidemiologists (22–25 April 2014). ▇▇▇▇▇▇▇▇-▇▇▇▇ ▇▇▇▇, MD, PhD ▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, MD ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇, MD, PhD ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ Hachom Wabo, PhD Manager, Regional Management Support Unit WHO Regional Office for Africa (AFRO) Brazzaville, Republic of Congo • Rehabilitated the National Influenza Laboratory which has become one of the best ...

LABORATORY ACTIVITIES. The SM&O Contractor undertakes to provide the following laboratory service on a monthly basis: (i) definition and analysis of the operation of the Plant; (ii) analysis of the Feedstock entering the Plant provided by the Client; (iii) determination of the energy potential for different types of feedstock by means of a “Standard Labscale Methane Production Test” (up to a maximum of 4 tests per year); (iv) a quarterly report on how the operation of the Plant can be improved.

LABORATORY ACTIVITIES. Processed and tested 1,706 specimens.

LABORATORY ACTIVITIES. Provided assistance to laboratories in the region to switch from serology-based surveillance to molecular methods. • Conducted standardized evaluations of influenza laboratory capabilities in each country by TEPHINET and PAHO experts with the CDC/APHL review tool. • Provided technical assistance to the NIC and decentralized influenza laboratories to update algorithms, SOPs, biosafety guidelines, and contingency plans. • Strengthened electronic laboratory information systems. • Participated in WHO’s External Quality Assessment Project (EQAP)—six NICs and two National Influenza Reference Laboratories. • Processed approximately 20,000 respiratory samples yearly (all influenza laboratories combined). • Assisted the Honduras NIC with calculating the sensitivity and specificity of the immunofluorescence assay. • Participated in ongoing discussions on the possibility of creating a regional reference laboratory and establishing an external quality control program on the immunofluorescence assay in the region. • Provided technical assistance to improve quality of cell culture, influenza virus isolation, and selection of isolates and specimens. • Conducted the core capabilities inventory to respond to influenza pandemic in all eight Central American countries. • Provided support for the development of an electronic platform to provide updated information to the rapid response teams to • Conducted a regional training workshop to address new WHO influenza surveillance standards and unusual respiratory events surveillance system. • Conducted several hands-on trainings at the NICs and decentralized laboratories. • Associations between seasonal influenza and meteorological parameters in Costa Rica, Honduras and Nicaragua. • Prevalence of influenza A virus in swine and duck populations in rural backyards within tropical wetlands in Guatemala, 2013. • Demographics and clinical characteristics of influenza A(H1N1)pdm09 virus-associated deaths in Central America and Dominican Republic 2009–2010. • Influenza illness among case-patients hospitalized for suspected dengue, El Salvador, 2012. • Incidence of influenza-associated severe acute respiratory infection among pregnant women in El Salvador. • Medical and economic burden of influenza-like illnesses and influenza-associated medically- attended illness. • Burden of influenza and influenza-associated pneumonia in the first year of life in a prospective cohort in Managua, Nicaragua. • Influenza-associated hospitalizations and ...

LABORATORY ACTIVITIES. Participated in WHO’s External Quality Assessment Project (EQAP) and received a score of 100% on the last panel. • Tested 613 samples, of which 97 (15.8%) were positive for an influenza virus: 38 were influenza A (H3N2) virus, 12 were influenza A (H1N1)pdm09, and 47 were influenza B. • Participated in a laboratory assessment in collaboration with CDC in order to identify strengths and opportunities in the laboratory. • Trained laboratory assistants at the regional laboratories on RT-PCR and influenza virus isolation methods. • Support from CDC has significantly advanced the level of influenza pandemic preparedness and planning. The Department of Disease Prevention and Sanitary Inspection, in conjunction with • Organized a round table for leaders of SSES centers to build capacity and help strengthen influenza surveillance at the local level. • Designed and printed pamphlets, checklists for parents, posters, and informational sheets on the main symptoms and tips on prevention to help raise awareness and educate the population of Kyrgyzstan about influenza (24,000 pcs). • Planned exercises to enhance pandemic preparedness with the concerned departments and ministries. • Purchased 343 suits with N-95 masks and glasses which were issued to nine regional centers of the Department of Disease Prevention and Sanitary Inspection. • Provided a workshop for 21 health care workers and laboratory staff on biosafety, storage, and transport of samples. • Provided training for nine laboratory experts on the laboratory diagnosis of influenza viruses in Bishkek, Osh, and Chui regions. • Provided training for doctors and epidemiologists at the regional and municipality levels on monitoring, analyzing, and identifying influenza outbreaks. • Improved the influenza sentinel surveillance system by strengthening hospital, polyclinic, and laboratory surveillance for ILI, ARI, and SARI. • Developed and implemented quality assurance measures—including External Quality Assurance Programs—at the NIC and at the nine surveillance sites. • Improved the influenza surveillance system by conducting workshops and trainings on influenza epidemiology, surveillance, and laboratory diagnosis.

LABORATORY ACTIVITIES. I understand that during the laboratory experiences I will role-play as both an EMT/PS and a patient. I will be expected to have physical contact with other students while learning various skills and have skills practiced on myself. Examples of such laboratory experiences may include patient exams, splinting, lifting and moving, assessment of vitals, venipuncture, etc. During the laboratory experiences I agree to follow theories and principles of safe, legal and ethical practice. I agree that I will not knowingly place myself, patients, preceptors or others in an unsafe situation based on my physical, mental, or emotional limitations. I have read the Physical Requirements for an EMT and noted any special requirements. I have read and agree to complete the physical exam and immunizations as required prior to patient contact.

LABORATORY ACTIVITIES. Collected 52 samples of viruses from October- December 2014, and shipped them to the WHO CC in Atlanta for sequencing. • Assigned the head of the NIC to participate in quality management training in France at Agence Française de la Normalisation (AFNOR) and helped conduct and evaluate a management policy based on quality (January 2014). • Trained a virologist on influenza sequencing and phylogenetic analysis at CDC Atlanta in November 2014.

LABORATORY ACTIVITIES. Contractor laboratory activities include but are not limited to: (1) all tasks relative to sampling, testing, and analysis of wastewater and effluent samples required for Water Reclamation Plant process control (2) self-monitoring, analysis, and reporting requirements per Permit and Regulatory Requirements (3) analysis of industrial waste samples collected during the compliance and follow-up inspections of permittees (4) analysis of wastewater samples required by contract with the City of Los Angeles (5) QA/QC program and documentation and maintenance of all records required by the City, Permit and Regulatory Requirements Contractor shall establish and maintain the necessary certification and registration to assure that the laboratory is in full conformance with Permit and Regulatory Requirements, including the Environmental Laboratory Accreditation Program (ELAP). All required tests and analyses are to be performed according to Permit Requirements and based on accepted methods for compliance monitoring programs. The methods applied will be based on 40 CFR Part 136, EPA-ATP, or DHS-ELAP with promulgated versions of and other Department of Health Services regulations, the latest edition of the Standard Methods for Examination of Water and Wastewater or USEPA amendments pertaining to existing ATP methods,